1 January 2025

Key bridge revealed in genetic communication of craniofacial development

A study co-led by the Alicante Institute of Neurosciences has discovered the genes that control cell migration, which is the basis for the development of facial structure. The work opens the way to a better understanding of the genetic causes behind certain congenital diseases.
30 December, 2024

A new drug improves clinical outcomes for patients with advanced breast cancer

A Phase 3 clinical trial demonstrates that the combination of imlunestrant and abemaciclib improves progression-free survival in advanced ER+ HER2- breast cancer, regardless of genomic profile. The compound as monotherapy only shows benefits in patients with mutations in the ESR1 gene.
27 December, 2024

A group of researchers develop an AI model to predict the risk of metabolic disorders in children with obesity

The system integrates epigenetic clinical data, allowing early detection and personalized prevention of metabolic complications, especially during puberty, a key stage to avoid future cardiovascular diseases.
26 December, 2024

A researcher from IIS Aragón chosen to represent women scientists in “Pioneers”

Rebeca Sanz, principal investigator of the Cancer Heterogeneity and Immunonomics group, is the star of the new edition of the Teruel Provincial Council calendar along with 11 other women from Bajo Aragón who are leaders in their fields.
24 December, 2024

The HUMS Urology Service has received two awards for its innovation and commitment to quality care in prostate cancer

Raquel Espílez and Ángel Borque, researchers at the IIS Aragón and specialists in the urology service at the Miguel Servet University Hospital, have received two important awards in the Third Call for Scholarships in Prostate Cancer Care Quality.